As of 2026-09-09, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.09) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -1870.3%.
The range of the Relative Valuation is (0.04) - (0.12) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 4.6x | 2.8x |
| Forward P/E multiples | 0.8x - 3.2x | 2.0x |
| Fair Price | (0.04) - (0.12) | (0.09) |
| Upside | -932.2% - -2436.1% | -1870.3% |
| Date | P/E |
| 2026-08-26 | -0.14 |
| 2026-08-21 | -0.27 |
| 2026-08-12 | -0.27 |
| 2026-08-07 | -0.27 |
| 2026-07-20 | -0.27 |
| 2026-07-17 | -0.27 |
| 2026-07-15 | -0.14 |
| 2026-07-03 | -0.27 |
| 2026-06-30 | -0.27 |
| 2026-06-29 | -0.27 |